Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 6, 2008, Pages 689-696

  Boyd, P A ^a   DeVigan, C ^b   Khoshnood, B ^b   Loane, M ^c   Garne, E ^d   Dolk, H ^c   Haeusler, Martin ^e   Gillerot, Yves ^e   Barisic, Ingeborg ^e   Christiansen, Marianne ^e   Ritvanen, Annukka ^e   Queisser Luft, Annette ^e   McDonnell, Bob ^e   Calzolari, Eliza ^e   Gatt, Miriam ^e   De Walle, Hermien ^e   Irgens, Lorentz ^e   Latos Bielenska, Anna ^e   Feijoo, Maria ^e   Portillo, Isabel ^e   Ollars, Birgitta ^e   Addor, Marie Claude ^e   Tucker, David ^e   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d KOLDING HOSPITAL   (Denmark)

^e NONE

Author keywords

Antenatal screening policy; Down's syndrome; Neural tube defect; Termination of pregnancy for fetal anomaly

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; DATA BASE; DOWN SYNDROME; EUROPE; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; LAW; NEURAL TUBE DEFECT; POPULATION RESEARCH; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER;

ABORTION, INDUCED; DOWN SYNDROME; EUROPE; FEMALE; GENETIC SCREENING; GESTATIONAL AGE; HEALTH POLICY; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY TRIMESTERS; PRENATAL DIAGNOSIS; QUESTIONNAIRES; ULTRASONOGRAPHY, PRENATAL;

EID: 41949130391     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.01700.x     Document Type: Article

References (17)

1. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997 4 : 181 246.
2. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al. First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005 353 : 2001 11.
3. Wald NJ, Watt HC, Hackshaw AK. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 1999 341 : 461 7.
4. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003 349 : 1405 13.
5. EUROCAT www.eurocat.ulster.ac.uk/pdf/EUROCAT-Guide-1.3.pdf www.eurocat.ulster.ac.uk/pdf/Special-Report-Prenatal-Diagnosis.pdf SD. Choice of effect measure for epidemiological data. J Clin Epidemiol 2000 53 : 931 9.
6. Robbins AS, Chao SY, Fonseca VP. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol 2002 12 : 452 4.
7. Leschot NJ, Vejerslev LO. Prenatal Diagnosis in Europe. Eur J Hum Genet 1997 5 (Suppl 1).
8. Boyd PA, Wellesley DG, De Walle HEK, Tenconi R, Garcia-Minaur S, Zandwijken GRJ, et al. Evaluation of the prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe. J Med Screen 2000 7 : 169 74.
9. Marteau TM. Towards informed decisions about prenatal testing: a review. Prenat Diagn 1995 15 : 1215 26.
10. Marteau TM. Prenatal testing: towards realistic expectations of patients, providers and policy makers. Ultrasound Obstet Gynecol 2002 19 : 5 6.
11. Asch A. Prenatal diagnosis and selective abortion: a challenge to practice and policy. Am J Public Health 1999 89 : 1649 57.
12. Marteau TM, Drake H. Attributions for disability: the influence of genetic screening. Soc Sci Med 1995 40 : 1127 32.
13. Mansfield C, Hopfer S, Marteau TM. Termination rates after prenatal diagnosis of Down's syndrome, spina bifida, anencephaly, and Turner and Klinefelter syndromes: a systematic literature review. European Concerted Action: DADA (Decision-making After the Diagnosis of a fetal Abnormality). Prenat Diagn 1999 19 : 808 12.
14. Bonnet D, Coltri A, Butera G, Fermont L, Le Bidois J, Kachaner J, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999 99 : 916 18.
15. Khoshnood B, De Vigan C, Vodovar V, Goujard J, Lhomme A, Bonnet D, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart defects in France, 1983-2000: a population-based evaluation. Pediatrics 2005 115 : 95 101.
16. Lo YM, Tsui NBY, Chiu RWK, Lau TK, Leung TN, Heung MM, et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 2007 13 : 218 23.
17. Dhallon R, Guo X, Emche S, Damewood M, Bayliss P, Cronin M, et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 2007 369 : 474 81.